Dr. Hatou presented recent research progress in Japan Cornea Conference 2021.
Tokyo (Feb 11, 2021)-, Dr. Hatou, founder & CEO of Cellusion Inc., presented recent research progress in Japan Cornea Conference 2021 held online from Feb. 11th to 13th. The presentation number and title are following.
The presentation number: O05
The Title: PoC study for CECSi Cells with Monkey Bullous Keratopathy Model.
With our cutting-edge cellular technology, Cellusion will accelerate our research program to deliver novel therapies for all bullous keratopathy patients.
Details on Japan Cornea Conference 2021, please see below. http://www.congre.co.jp/cornea2021/
Cellusion Inc. is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.
Company ： Cellusion Inc.
CEO ： Shin Hatou, M.D., Ph.D.
Headquarter ：1-13-7 Nihombashi-Muromachi, Chuo, Tokyo 103-0022, JAPAN
Founded ： January 2015
URL ： https://cellusion.jp/en/